Managing pain after cesarean section surgery
Postoperative Pain Management of Caesarean Section: a Prospective, Observational Cohort Study
Mackay Memorial Hospital · NCT05009771
This study is testing different pain relief methods after cesarean section surgery to see which ones help new mothers recover better and feel less pain.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 20 Years to 40 Years |
| Sex | Female |
| Sponsor | Mackay Memorial Hospital (other) |
| Locations | 2 sites (New Taipei City, Taiwan and 1 other locations) |
| Trial ID | NCT05009771 on ClinicalTrials.gov |
What this trial studies
This observational cohort study aims to evaluate the effectiveness of various postoperative analgesic methods for patients undergoing elective cesarean sections. Participants will provide informed consent and have their data collected through medical records, questionnaires, and follow-up telephone visits. The study will assess pain intensity, analgesic consumption, recovery time, and the impact of pain on postpartum depression over a period of three months. The goal is to identify optimal pain management strategies to improve recovery outcomes for new mothers.
Who should consider this trial
Good fit: Ideal candidates are women aged 20 to 40 who are planning to undergo elective cesarean sections with spinal anesthesia.
Not a fit: Patients with chronic pain diseases, mental illnesses, or contraindications to opioids or NSAIDs may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for women after cesarean sections, enhancing their recovery and overall well-being.
How similar studies have performed: Previous studies have shown varying success with different analgesic methods in postoperative pain management, making this approach both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 20 to 40. 2. Planing to undergo caesarean section with spinal anesthesia. 3. Scheduled to undergo cesarean section between 37 and 40 weeks of gestation. 4. American Society of Anesthesiology Physical Class 1-2. 5. Planing to alleviate postoperative pain with intravenous patient-controlled analgesia or administration of NALDEBAIN. Exclusion Criteria: 1. Not willing to provide informed consent. 2. Unable to receive opioids or NSAIDs due to contraindication. 3. Long-term use of opioids or drug abuse. 4. Suffering from chronic pain disease. 5. Having medical history of mental illnesses. 6. Diagnosed with Pre-eclampsia or eclampsia. 7. Diagnosed with gestational diabetes. 8. Unsuitable for participation judged by investigator.
Where this trial is running
New Taipei City, Taiwan and 1 other locations
- MacKay Memorial Hospital Tamsui Branch — New Taipei City, Taiwan, Taiwan (RECRUITING)
- MacKay Memorial Hospital — Taipei, Taiwan, Taiwan (NOT_YET_RECRUITING)
Study contacts
- Principal investigator: Chi-Hsu Wang, M.D. — MacKay Memorial Hospital Tamsui Branch
- Study coordinator: Chi-Hsu Wang, M.D.
- Email: s871017@gmail.com
- Phone: +886-2-2809-4661
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Postoperative Pain, Caesarean Section, Analgesia, Caesarean section, Postpartum rehabilitation, Dinalbuphine sebacate, PCA, NALDEBAIN